Takeda Ends Development of Another Celiac Disease Drug, Leaving One Major Candidate in Its Pipeline

Celiac.com Articles

Celiac.com 09/11/2026 - Takeda has discontinued development of another experimental treatment for celiac disease, narrowing its once-broad drug pipeline for the condition to a single remaining phase two candidate. The de...View more